Scarica l'app Stockscreener
6.72
1.05%
0.07
Dopo l'orario di chiusura:
6.72
Precedente Chiudi:
$6.65
Aprire:
$6.67
Volume 24 ore:
281.64K
Relative Volume:
1.03
Capitalizzazione di mercato:
$185.03M
Reddito:
$61.86M
Utile/perdita netta:
$-11.43M
Rapporto P/E:
-13.95
EPS:
-0.4818
Flusso di cassa netto:
$-12.52M
1 W Prestazione:
+4.51%
1M Prestazione:
-5.62%
6M Prestazione:
-13.07%
1 anno Prestazione:
-7.44%
Intervallo 1D:
$6.505
$6.80
Intervallo di 1 settimana:
$6.22
$7.64
Portata 52W:
$4.31
$9.555
Journey Medical Corp Stock (DERM) Company Profile
Nome
Journey Medical Corp
Settore
Telefono
480-434-6670
Indirizzo
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
6.72 | 177.05M | 61.86M | -11.43M | -12.52M | -0.4818 |
TAK
Takeda Pharmaceutical Co Adr
|
17.63 | 55.60B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.77 | 42.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.70 | 43.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.79 | 30.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
499.73 | 21.95B | 3.17B | 1.29B | 1.01B | 27.09 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-30 | Ripresa | B. Riley Securities | Buy |
| 2024-08-22 | Iniziato | Rodman & Renshaw | Buy |
| 2024-06-28 | Ripresa | ROTH MKM | Buy |
| 2021-12-07 | Iniziato | B. Riley Securities | Buy |
Journey Medical Corp Borsa (DERM) Ultime notizie
Teleconferência de Resultados do 2T26 da Journey Medical (FBIO): Receita cresce 23% com aceleração do Emrosi - TradingKey
Q3 EPS Estimates for Journey Medical Cut by HC Wainwright - marketbeat.com
Conferencia de resultados del T2 de 2026 de Journey Medical (FBIO): los ingresos aumentan un 23% a medida que Emrosi se acelera - TradingKey
Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates - tradingkey.com
Journey Medical (DERM) Stock Eyes Break Even As Emrosi Gains Traction - Sahm
Analyst Reiterates Buy on Journey Medical as Emrosi Outperformance Supports Unchanged $13 Price Target - TipRanks
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey - The Manila Times
Journey Medical's (DERM) Buy Rating Reaffirmed at B. Riley Financial - marketbeat.com
Why is Journey Medical stock rallying today? - Investing.com
Why is Journey Medical stock rallying today? By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Wasatch Advisors LP Buys 725,560 Shares of Journey Medical Corporation $DERM - marketbeat.com
Journey Medical Corp (DERM) (Q2 2026) Earnings Call Highlights: Emrosi Surges 20% Sequentially, ... - Yahoo Finance
Journey Medical earnings beat by $0.12, revenue topped estimates - Investing.com Australia
DERM Looks 49.2% Overvalued on GF Value™ - GuruFocus
Journey Medical Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Journey Medical Q2 Earnings Call Highlights - marketbeat.com
Here's What Key Metrics Tell Us About Journey Medical (DERM) Q2 Earnings - Yahoo Finance
Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Earnings call transcript: Journey Medical tops Q2 2026 forecasts as stock rises - Investing.com
Earnings call transcript: Journey Medical posts Q2 2026 revenue gain, turns EBITDA positive - Investing.com
Journey Medical (NASDAQ:DERM) Posts Earnings Results, Beats Expectations By $0.04 EPS - marketbeat.com
Journey Medical (DERM) grows Emrosi sales but flags going concern risk - Stock Titan
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - Yahoo Finance
Earnings To Watch: Journey Medical Corp (DERM) Q2 2026 -- GF Val - GuruFocus
Earnings To Watch: Journey Medical Corp (DERM) Q2 2026 -- GF Value Sees 6% Upside - Yahoo Finance
From the hardwood to healthcare: CEO Stephen Flatt’s journey to the top of long-term care - McKnight's Long-Term Care News
Journey Medical Corp expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Journey Medical Corp (DERM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 - Yahoo Finance
Journey Medical (DERM) Expected to Post Earnings on Tuesday - marketbeat.com
Vanguard Capital Management (DERM) discloses 774,556 Journey Medical shares in 13G/A - Stock Titan
Journey Medical Corp (DERM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Journey Medical Corp (DERM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
DERM|Journey Medical Corp|Price:6.360|Chg%:+0.170 - TradingKey
Journey Medical Corp (DERM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Journey Medical Corp (DERM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Journey Medical Corp (DERM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Journey Medical Corp (DERM) Cash Flow - TradingKey
Journey Medical Corp|Price:6.190|Chg%:-0.390 - TradingKey
DERM stock holds focus on Journey Medical Corp results - Ad-hoc-news.de
WASATCH ADVISORS LP Acquires Additional Shares in Journey Medica - GuruFocus
DERM Stock Price, Quote & Chart - ChartMill
Mount Grace Hospitals Launches Medico Concierge Kiosk and Patient Portal to Transform Digital Patient Journey - Daily Tribune
Top medical emergencies covered under travel medical insurance - Adgully.com
Journey Medical (DERM) gains 13.3% shareholder in Wasatch Advisors - Stock Titan
Journey Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Journey Medical Corp focuses on dermatology growth. DERM stock reflects a specialized niche strategy - Ad Hoc News
Journey Medical (DERM) Falls Over 6% as Shares Approach Key Support LevelSafe Entry Stocks - dars.gov.et
Form 4 Journey Medical Corp For: 2 July By Investing.com - Investing.com Canada
Journey Medical (DERM) grants director 50,000 restricted stock units - Stock Titan
Journey Medical Corp Azioni (DERM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.79%
5.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):